The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3-fluorophenyl)(2-hydroxy-4,6-dimethoxy-3-(piperidin-1-ylmethyl)phenyl)methanone ID: ALA1091429
PubChem CID: 46884377
Max Phase: Preclinical
Molecular Formula: C21H24FNO4
Molecular Weight: 373.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(OC)c(C(=O)c2cccc(F)c2)c(O)c1CN1CCCCC1
Standard InChI: InChI=1S/C21H24FNO4/c1-26-17-12-18(27-2)19(20(24)14-7-6-8-15(22)11-14)21(25)16(17)13-23-9-4-3-5-10-23/h6-8,11-12,25H,3-5,9-10,13H2,1-2H3
Standard InChI Key: AYYZBQFQHSBUDN-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
10.2361 -23.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2349 -24.0023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9497 -24.4152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6662 -24.0019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6633 -23.1713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9479 -22.7622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5201 -24.4143 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8060 -24.0012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9455 -21.9372 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6587 -21.5226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3813 -24.4132 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3762 -22.7561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0922 -23.1659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3731 -21.9311 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0920 -23.9886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8072 -24.3983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5211 -23.9831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5153 -23.1538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7995 -22.7478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9495 -25.2402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2350 -25.6525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5217 -25.2415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8093 -25.6503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8048 -26.4756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5190 -26.8905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2377 -26.4800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2267 -22.7361 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
12 14 2 0
2 7 1 0
13 15 2 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
17 18 1 0
6 9 1 0
18 19 2 0
19 13 1 0
4 5 1 0
3 20 1 0
9 10 1 0
20 21 1 0
21 22 1 0
2 3 1 0
4 11 1 0
5 6 2 0
5 12 1 0
6 1 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
12 13 1 0
18 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 373.42Molecular Weight (Monoisotopic): 373.1689AlogP: 3.77#Rotatable Bonds: 6Polar Surface Area: 59.00Molecular Species: ACIDHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 5.70CX Basic pKa: 8.14CX LogP: 3.19CX LogD: 3.16Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.78Np Likeness Score: -0.42
References 1. Bandgar BP, Patil SA, Totre JV, Korbad BL, Gacche RN, Hote BS, Jalde SS, Chavan HV.. (2010) Synthesis and biological evaluation of nitrogen-containing benzophenone analogues as TNF-alpha and IL-6 inhibitors with antioxidant activity., 20 (7): [PMID:20207143 ] [10.1016/j.bmcl.2010.02.001 ]